7 results
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
Measurement in SLE ... Hydroxychloroquine #HCQ ... #rheumatology # ... pharmacology #levels ... #lupus #management
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
patients genotype, treatment ... cirrhosis status to see ... /ambcarerx #HCV ... #Medications #Naming ... #DAAs #Pharmacology
Hydroxychloroquine - Risks and Benefits in Lupus
Benefits:
↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
and Benefits in Lupus ... recommended with other medications ... Hydroxychloroquine #hcq ... #Lupus #pharmacology ... #sideeffects #rheumatology
Drug Induced Systemic Lupus Erythematosus
> 100 drugs have been associated with drug-induced SLE
High risk (>5%):
 •
Induced Systemic Lupus ... for 1 year of treatment ... Erythematosus #medications ... #drugs #pharmacology ... #diagnosis #rheumatology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
SLE (Systemic Lupus ... Non-autoimmune rheumatologic ... C4 accompanies flares ... Thrombosis highest risk ... activation and/or medications
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... effusion, INC risk ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Infections in HIV-AIDS ... Indications for ... mm3 and at high risk ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology